Loss of ACE2 Exacerbates Murine Renal Ischemia-Reperfusion Injury

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Fang, Fei ^a   Liu, George Chu ^a   Zhou, Xiaohua ^a   Yang, Stuart ^b   Reich, Heather Naomi ^b   Williams, Vanessa ^a   Hu, Amanda ^a   Pan, Janice ^a   Konvalinka, Ana ^a   Oudit, Gavin Yadram ^c   Scholey, James William ^a,b   John, Rohan ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

ACE2 GENE; ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE DELETION; GENE LOSS; HISTOLOGY; HISTOPATHOLOGY; INFLAMMATION; KIDNEY FUNCTION; KNOCKOUT MOUSE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RENAL PROTECTION; REPERFUSION INJURY; T LYMPHOCYTE; WILD TYPE;

EID: 84881230942     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071433     Document Type: Article

References (54)

1. Lai CF, Wu VC, Huang TM, Yeh YC, Wang KC, et al. (2012) Kidney function decline after a non-dialysis-requiring acute kidney injury is associated with higher long-term mortality in critically ill survivors. Crit Care 16: R123.
2. Goldberg R, Dennen P, (2008) Long-term outcomes of acute kidney injury. Adv Chronic Kidney Dis 15: 297-307.
3. Peeters P, Terryn W, Vanholder R, Lameire N, (2004) Delayed graft function in renal transplantation. Curr Opin Crit Care 10: 489-498.
4. Schrier RW, Wang W, Poole B, Mitra A, (2004) Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 114: 5-14.
5. Devarajan P, (2006) Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 17: 1503-1520.
6. Bonventre JV, Zuk A, (2004) Ischemic acute renal failure: an inflammatory disease? Kidney Int 66: 480-485.
7. de Zeeuw D, Lewis EJ, Remuzzi G, Brenner BM, Cooper ME (2006) Renoprotective effects of renin-angiotensin-system inhibitors. Lancet 367: 899-900; author reply 900-892.
8. Taal MW, Brenner BM, (2000) Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney Int 57: 1803-1817.
9. Ruiz-Ortega M, Ruperez M, Esteban V, Rodriguez-Vita J, Sanchez-Lopez E, et al. (2006) Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant 21: 16-20.
10. Ruster C, Wolf G, (2006) Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephrol 17: 2985-2991.
11. da Silveira KD, Pompermayer Bosco KS, Diniz LR, Carmona AK, Cassali GD, et al. (2010) ACE2-angiotensin-(1-7)-Mas axis in renal ischaemia/reperfusion injury in rats. Clin Sci (Lond) 119: 385-394.
12. Allred AJ, Chappell MC, Ferrario CM, Diz DI, (2000) Differential actions of renal ischemic injury on the intrarenal angiotensin system. Am J Physiol Renal Physiol 279: F636-645.
13. Kontogiannis J, Burns KD, (1998) Role of AT1 angiotensin II receptors in renal ischemic injury. Am J Physiol 274: F79-90.
14. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, et al. (2000) A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275: 33238-33243.
15. Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, et al. (2003) Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A 100: 8258-8263.
16. Zimmerman D, Burns KD, (2012) Angiotensin-(1-7) in kidney disease: a review of the controversies. Clin Sci (Lond) 123: 333-346.
17. Iwata M, Cowling RT, Gurantz D, Moore C, Zhang S, et al. (2005) Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects. Am J Physiol Heart Circ Physiol 289: H2356-2363.
18. Oudit GY, Herzenberg AM, Kassiri Z, Wong D, Reich H, et al. (2006) Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am J Pathol 168: 1808-1820.
19. Soler MJ, Wysocki J, Ye M, Lloveras J, Kanwar Y, et al. (2007) ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney Int 72: 614-623.
20. Wong DW, Oudit GY, Reich H, Kassiri Z, Zhou J, et al. (2007) Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am J Pathol 171: 438-451.
21. Dilauro M, Zimpelmann J, Robertson SJ, Genest D, Burns KD, (2010) Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease. Am J Physiol Renal Physiol 298: F1523-1532.
22. Liu Z, Huang XR, Chen HY, Penninger JM, Lan HY, (2012) Loss of angiotensin-converting enzyme 2 enhances TGF-beta/Smad-mediated renal fibrosis and NF-kappaB-driven renal inflammation in a mouse model of obstructive nephropathy. Lab Invest 92: 650-661.
23. Oudit GY, Liu GC, Zhong J, Basu R, Chow FL, et al. (2010) Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes 59: 529-538.
24. Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, et al. (2002) Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417: 822-828.
25. Wijsman JH, Jonker RR, Keijzer R, van de Velde CJ, Cornelisse CJ, et al. (1993) A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem 41: 7-12.
26. Kelly KJ, Sandoval RM, Dunn KW, Molitoris BA, Dagher PC, (2003) A novel method to determine specificity and sensitivity of the TUNEL reaction in the quantitation of apoptosis. Am J Physiol Cell Physiol 284: C1309-1318.
27. Tilney NL, Guttmann RD, (1997) Effects of initial ischemia/reperfusion injury on the transplanted kidney. Transplantation 64: 945-947.
28. Chawla LS, Kimmel PL (2012) Acute kidney injury and chronic kidney disease: an integrated clinical syndrome. Kidney Int.
29. Lieberthal W, Menza SA, Levine JS, (1998) Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells. Am J Physiol 274: F315-327.
30. Brodsky SV, Yamamoto T, Tada T, Kim B, Chen J, et al. (2002) Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am J Physiol Renal Physiol 282: F1140-1149.
31. Sutton TA, Mang HE, Campos SB, Sandoval RM, Yoder MC, et al. (2003) Injury of the renal microvascular endothelium alters barrier function after ischemia. Am J Physiol Renal Physiol 285: F191-198.
32. Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, et al. (2007) TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 117: 2847-2859.
33. Friedewald JJ, Rabb H, (2004) Inflammatory cells in ischemic acute renal failure. Kidney Int 66: 486-491.
34. Farrar CA, Wang Y, Sacks SH, Zhou W, (2004) Independent pathways of P-selectin and complement-mediated renal ischemia/reperfusion injury. Am J Pathol 164: 133-141.
35. Singbartl K, Ley K, (2004) Leukocyte recruitment and acute renal failure. J Mol Med (Berl) 82: 91-101.
36. Frangogiannis NG, (2007) Chemokines in ischemia and reperfusion. Thromb Haemost 97: 738-747.
37. Kelly KJ, Plotkin Z, Vulgamott SL, Dagher PC, (2003) P53 mediates the apoptotic response to GTP depletion after renal ischemia-reperfusion: protective role of a p53 inhibitor. J Am Soc Nephrol 14: 128-138.
38. Quadri SM, Segall L, de Perrot M, Han B, Edwards V, et al. (2005) Caspase inhibition improves ischemia-reperfusion injury after lung transplantation. Am J Transplant 5: 292-299.
39. Doi K, Suzuki Y, Nakao A, Fujita T, Noiri E, (2004) Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney. Kidney Int 65: 1714-1723.
40. Esteban V, Ruperez M, Vita JR, Lopez ES, Mezzano S, et al. (2003) Effect of simultaneous blockade of AT1 and AT2 receptors on the NFkappaB pathway and renal inflammatory response. Kidney Int Suppl: S33-38.
41. Batlle D, Soler MJ, Wysocki J, (2008) New aspects of the renin-angiotensin system: angiotensin-converting enzyme 2- a potential target for treatment of hypertension and diabetic nephropathy. Curr Opin Nephrol Hypertens 17: 250-257.
42. Magnusson MO, Rybka SJ, Stowe NT, Novick AC, Straffon RA (1983) Enhancement of recovery in postischemic acute renal failure with captopril. Kidney Int Suppl 16: S324-326.
43. Long GW, Misra DC, Juleff R, Blossom G, Czako PF, et al. (1993) Protective effects of enalaprilat against postischemic renal failure. J Surg Res 54: 254-257.
44. Singh V, Jain S, Gowthaman U, Parihar P, Gupta P, et al. (2011) Co-administration of IL-1+IL-6+TNF-alpha with Mycobacterium tuberculosis infected macrophages vaccine induces better protective T cell memory than BCG. PLoS One 6: e16097.
45. Schreiber S, Nikolaus S, Hampe J, Hamling J, Koop I, et al. (1999) Tumour necrosis factor alpha and interleukin 1beta in relapse of Crohn's disease. Lancet 353: 459-461.
46. Dong X, Swaminathan S, Bachman LA, Croatt AJ, Nath KA, et al. (2007) Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int 71: 619-628.
47. Matsumoto M, Makino Y, Tanaka T, Tanaka H, Ishizaka N, et al. (2003) Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats. J Am Soc Nephrol 14: 1825-1832.
48. Esteban V, Heringer-Walther S, Sterner-Kock A, de Bruin R, van den Engel S, et al. (2009) Angiotensin-(1-7) and the g protein-coupled receptor MAS are key players in renal inflammation. PLoS One 4: e5406.
49. Iwai M, Horiuchi M, (2009) Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis. Hypertens Res 32: 533-536.
50. Su Z, Zimpelmann J, Burns KD, (2006) Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int 69: 2212-2218.
51. Liu GC, Oudit GY, Fang F, Zhou J, Scholey JW, (2012) Angiotensin-(1-7)-induced activation of ERK1/2 is cAMP/protein kinase A-dependent in glomerular mesangial cells. Am J Physiol Renal Physiol 302: F784-790.
52. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, et al. (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87: E1-9.
53. Batlle D, Wysocki J, Soler MJ, Ranganath K, (2012) Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy. Kidney Int 81: 520-528.
54. Rey-Parra GJ, Vadivel A, Coltan L, Hall A, Eaton F, et al. (2012) Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury. J Mol Med (Berl) 90: 637-647.